—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Liquidia Technologies Inc (LQDA) — Technical state

As of 2026-11-10 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 46 out of 100 (momentum 23 · quality 68 · valuation 30), as of 2026-11-11.
  • Signal: Recovery attempt under the 200-day — Trades +3.5% vs the 50-day and -5.7% vs the 200-day average, 45.1% below the 52-week high and +130.4% off the 52-week low; a death cross printed 10 sessions ago. Computed from daily closes. (as of 2026-11-10)
  • Trend: Liquidia Technologies Inc trades 3.5% above its 50-day and 5.7% below its 200-day moving average. (as of 2026-11-10)

Liquidia Technologies develops and sells therapies for rare heart-and-lung diseases, mainly pulmonary hypertension. Its lead product, Yutrepia, is an inhaled dry-powder form of treprostinil, and it also sells Remodulin, an injected version of the same drug given through a pump.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the LQDA overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Recovery attempt under the 200-day

Trades +3.5% vs the 50-day and -5.7% vs the 200-day average, 45.1% below the 52-week high and +130.4% off the 52-week low; a death cross printed 10 sessions ago. Computed from daily closes.

Ranked #35 on today’s Directional Flow — Falling fastest list (scan of 2026-11-10).

The moving-average stack

Continue: the LQDA chart & overview · quality & forensics · the earnings record · the signal board

FAQ · from the current data · as of 2026-11-10

Quick answers

What is the current Closelooknet signal on LQDA?

Recovery attempt under the 200-day — Trades +3.5% vs the 50-day and -5.7% vs the 200-day average, 45.1% below the 52-week high and +130.4% off the 52-week low; a death cross printed 10 sessions ago. Computed from daily closes. As of 2026-11-10; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is LQDA above its 50-day and 200-day moving averages?

As of 2026-11-10, Liquidia Technologies Inc trades +3.5% above its 50-day and -5.7% below its 200-day average, with the 20-day +22.5% away.

How far is LQDA from its 52-week high?

45.1% below the 52-week high and 130.4% above the 52-week low, as of 2026-11-10.

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.